Angiotensin type 2 receptor signaling in satellite cells potentiates skeletal muscle regeneration

Journal of Biological Chemistry

Volumn 289, Issue 38, 2014, Pages 26239-26248

  Yoshida, Tadashi ^a   Huq, Tashfin S ^a   Delafontaine, Patrice ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION ANALYSIS; MUSCLE; NEURONS;

ANGIOTENSIN II; MUSCLE WASTING; MYOBLASTS; RECEPTOR SIGNALING; RENIN-ANGIOTENSIN SYSTEM; SATELLITE CELLS; SKELETAL MUSCLE;

CELL SIGNALING;

ANGIOTENSIN 2 RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; 1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; IMIDAZOLE DERIVATIVE; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; OLIGOPEPTIDE; PYRIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AT2R GENE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; EXTENSOR DIGITORUM LONGUS MUSCLE; GASTROCNEMIUS MUSCLE; GENE ACTIVATION; GENE EXPRESSION; MALE; MOUSE; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE SATELLITE CELL; TIBIALIS ANTERIOR MUSCLE; AGONISTS; ANIMAL; C57BL MOUSE; CELL LINE; CYTOLOGY; METABOLISM; PHYSIOLOGY; REGENERATION; SKELETAL MUSCLE;

ANGIOTENSIN II TYPE 2 RECEPTOR BLOCKERS; ANIMALS; CELL DIFFERENTIATION; CELL LINE; GENE EXPRESSION; IMIDAZOLES; MALE; MAP KINASE SIGNALING SYSTEM; MICE, INBRED C57BL; MUSCLE, SKELETAL; OLIGOPEPTIDES; PYRIDINES; RECEPTOR, ANGIOTENSIN, TYPE 2; REGENERATION; SATELLITE CELLS, SKELETAL MUSCLE;

EID: 84907220384     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.585521     Document Type: Article

References (49)

1. Werner, C, Pöss, J., and Böhm, M. (2010) Optimal antagonism of the renin-angiotensin-aldosterone system: do we need dual or triple therapy? Drugs 70, 1215-1230
2. Brink, M., Wellen, J., and Delafontaine, P. (1996) Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism. J. Clin. Invest. 97, 2509-2516
3. Brink, M., Price, S. R., Chrast, J., Bailey, J. L., Anwar, A., Mitch, W. E., and Delafontaine, P. (2001) Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I. Endocrinology 142, 1489-1496
4. Song, Y.-H., Li, Y., Du, J., Mitch, W. E., Rosenthal, N., and Delafontaine, P. (2005) Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. J. Clin. Invest. 115, 451-458
5. Yoshida, T., Semprun-Prieto, L., Sukhanov, S., and Delafontaine, P. (2010) IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt-and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression. Am. J. Physiol. Heart Circ. Physiol. 298, H1565-H1570
6. Yoshida, T., Semprun-Prieto, L., Wainford, R. D., Sukhanov, S., Kapusta, D. R., and Delafontaine, P. (2012) Angiotensin II reduces food intake by altering orexigenic neuropeptide expression in the mouse hypothalamus. Endocrinology 153, 1411-1420
7. Semprun-Prieto, L. C., Sukhanov, S., Yoshida, T., Rezk, B. M., Gonzalez-Villalobos, R. A., Vaughn, C., Michael Tabony, A., and Delafontaine, P. (2011) Angiotensin II induced catabolic effect and muscle atrophy are redox dependent. Biochem. Biophys. Res. Comm. 409, 217-221
8. Tabony, A. M., Yoshida, T., Galvez, S., Higashi, Y., Sukhanov, S., Chan-drasekar, B., Mitch, W. E., and Delafontaine, P. (2011) Angiotensin II upregulates protein phosphatase 2Ca and inhibits AMP-activated protein kinase signaling and energy balance leading to skeletal muscle wasting. Hypertension 58, 643-649
9. Rezk, B. M., Yoshida, T., Semprun-Prieto, L., Higashi, Y., Sukhanov, S., and Delafontaine, P. (2012) Angiotensin II infusion induces marked diaphragmatic skeletal muscle atrophy. PLoS ONE 7, e30276
10. Sanders, P. M., Russell, S. T., and Tisdale, M. J. (2005) Angiotensin II directly induces muscle protein catabolism through the ubiquitin-protea-some proteolytic pathway and may play a role in cancer cachexia. Br. J. Cancer 93, 425-434
11. Russell, S. T., Sanders, P. M., and Tisdale, M. J. (2006) Angiotensin II directly inhibits protein synthesis in murine myotubes. Cancer Lett. 231, 290-294
12. Morales, M. G., Vazquez, Y., Acuña, M. J., Rivera, J. C, Simon, F., Salas, J. D., Alvarez Ruf, J., Brandan, E., and Cabello-Verrugio, C. (2012) Angiotensin II-induced pro-fibrotic effects require p38MAPK activity and transforming growth factor β1 expression in skeletal muscle cells. Int. J. Biochem. Cell Biol. 44, 1993-2002
13. Roig, E., Perez-Villa, F., Morales, M., Jiménez, W., Orús, J., Heras, M., and Sanz, G. (2000) Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure. Eur. Heart J. 21, 53-57
14. Anker, S. D., Negassa, A., Coats, A. J., Afzal, R., Poole-Wilson, P. A., Cohn, J. N., and Yusuf, S. (2003) Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 361, 1077-1083
15. Masson, S., Latini, R., Bevilacqua, M., Vago, T., Sessa, F., Torri, M., Ane-sini, A., Salio, M., Pasotti, E., Agnello, D., Santoro, L., Catania, A., Ghezzi, P., Moccetti, T., and Maggioni, A. P. (1998) Within-patient variability of hormone and cytokine concentrations in heart failure. Pharmacol. Res. 37, 213-217
16. Tan, B. H., and Fearon, K. C (2008) Cachexia: prevalence and impact in medicine. Curr. Opin. Clin. Nutr. Metab. Care 11, 400-407
17. Dalla Libera, L., Ravara, B., Angelini, A., Rossini, K., Sandri, M., Thiene, G., Battista Ambrosio, G., and Vescovo, G. (2001) Beneficial effects on skeletal muscle of the angiotensin II type 1 receptor blocker irbesartan in experimental heart failure. Circulation 103, 2195-2200
18. Zhang, L., Du, J., Hu, Z., Han, G., Delafontaine, P., Garcia, G., and Mitch, W. E. (2009) IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting. J. Am. Soc. Nephrol. 20, 604-612
19. Yoshida, T., Galvez, S., Tiwari, S., Rezk, B. M., Semprun-Prieto, L., Higashi, Y., Sukhanov, S., Yablonka-Reuveni, Z., and Delafontaine, P. (2013) Angiotensin II inhibits satellite cell proliferation and prevents skeletal muscle regeneration. J. Biol. Chem. 288, 23823-23832
20. Yablonka-Reuveni, Z., and Day, K. (2011) in Regenerating the Heart (Cohen, I. S., and Gaudette, G. R., eds), pp. 173-200, Springer
21. Cohn, R. D., van Erp, C, Habashi, J. P., Soleimani, A. A., Klein, E. C, Lisi, M. T., Gamradt, M., ap Rhys, C. M., Holm, T. M., Loeys, B. L., Ramirez, F., Judge, D. P., Ward, C. W., and Dietz, H. C. (2007) Angiotensin II type 1 receptor blockade attenuates TGF-β-induced failure of muscle regeneration in multiple myopathic states. Nat Med. 13, 204-210
22. Bedair, H. S., Karthikeyan, T., Quintero, A., Li, Y., and Huard, J. (2008) Angiotensin II receptor blockade administered after injury improves muscle regeneration and decreases fibrosis in normal skeletal muscle. Am. J. Sports Med. 36, 1548-1554
23. Johnston, A. P., Baker, J., Bellamy, L. M., McKay, B. R., De Lisio, M., and Parise, G. (2010) Regulation of muscle satellite cell activation and che-motaxis by angiotensin II. PLoS ONE 5, e15212
24. -/-mice enhances muscle function despite reducing muscle mass but compromises repair after injury. Am. J. Physiol. Regul. Integr. Comp. Physiol. 303, R321-R331
25. Yan, Z., Choi, S., Liu, X., Zhang, M., Schageman, J. J., Lee, S. Y., Hart, R., Lin, L., Thurmond, F. A., and Williams, R. S. (2003) Highly coordinated gene regulation in mouse skeletal muscle regeneration. J. Biol. Chem. 278, 8826-8836
26. Conboy, I. M., Conboy, M. J., Smythe, G. M., and Rando, T. A. (2003) Notch-mediated restoration of regenerative potential to aged muscle. Science 302, 1575-1577
27. Conboy, I. M., and Rando, T. A. (2002) The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis. Dev. Cell3, 397-409
28. Blankley, C. J., Hodges, J. C, Klutchko, S. R., Himmelsbach, R. J., Chucholowski, A., Connolly, C. J., Neergaard, S. J., Van Nieuwenhze, M. S., Sebastian, A., and Quin, J. (1991) Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtype. J. Med. Chem. 34, 3248-3260
29. Broderick, K. E., Chan, A., Lin, F., Shen, X., Kichaev, G., Khan, A. S., Aubin, J., Zimmermann, T. S., and Sardesai, N Y. (2012) Optimized in vivo transfer of small interfering RNA targeting dermal tissue using in vivo surface electroporation. Mol. Ther. Nucleic Acids 1, e11
30. Bennett, A. M., and Tonks, N. K. (1997) Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science 278, 1288-1291
31. Nakajima, M., Hutchinson, H. G., Fujinaga, M., Hayashida, W., Morishita, R., Zhang, L., Horiuchi, M., Pratt, R. E., and Dzau, V J. (1995) The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc. Natl. Acad. Sci. U.S.A. 92, 10663-10667
32. Agoudemos, M. M., and Greene, A. S. (2005) Localization of the renin-angiotensin system components to the skeletal muscle microcirculation. Microcirculation 12, 627-636
33. Johnston, A. P., Baker, J., De Lisio, M., and Parise, G. (2011) Skeletal muscle myoblasts possess a stretch-responsive local angiotensin signalling system. J. Renin Angiotensin Aldosterone Syst. 12, 75-84
34. Echeverría-Rodríguez, O., Del Valle-Mondragón, L., and Hong, E. (2014) Angiotensin 1-7 improves insulin sensitivity by increasing skeletal muscle glucose uptake in vivo. Peptides 51, 26-30
35. Prasannarong, M., Santos, F. R., and Henriksen, E. J. (2012) ANG-(1-7) reduces ANG II-induced insulin resistance by enhancing Akt phosphorylation via a Mas receptor-dependent mechanism in rat skeletal muscle. Biochem. Biophys. Res. Comm. 426, 369-373
36. Riquelme, C, Acuña, M. J., Torrejón, J., Rebolledo, D., Cabrera, D., Santos, R. A., and Brandan, E. (2014) ACE2 is augmented in dystrophic skeletal muscle and plays a role in decreasing associated fibrosis. PLoS ONE 9, e93449
37. Painemal, P., Acuña, M. J., Riquelme, C, Brandan, E., and Cabello-Verrugio, C. (2013) Transforming growth factor type β 1. BioFactors 39, 467-475
38. deGasparo, M., Catt, K. J., Inagami, T., Wright, J. W., and Unger, T. (2000) International union of pharmacology: XXIII: The angiotensin II receptors. Pharmacol. Rev. 52, 415-472
39. Akishita, M., Horiuchi, M., Yamada, H, Zhang, L., Shirakami, G., Tamura, K., Ouchi, Y., and Dzau, V. J. (2000) Inflammation influences vascular remodeling through AT2 receptor expression and signaling. Physiol. Genomics 2, 13-20
40. Masaki, H, Kurihara, T., Yamaki, A., Inomata, N, Nozawa, Y., Mori, Y., Murasawa, S., Kizima, K., Maruyama, K., Horiuchi, M., Dzau, V. J., Taka-hashi, H., Iwasaka, T., Inada, M., and Matsubara, H. (1998) Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects. J. Clin. Invest. 101, 527-535
41. Widdop, R. E., Jones, E. S., Hannan, R. E., and Gaspari, T. A. (2003) Angiotensin AT2 receptors: cardiovascular hope or hype? Br. J. Pharmacol. 140, 809-824
42. Reinecke, K., Lucius, R., Reinecke, A., Rickert, U., Herdegen, T., and Unger, T. (2003) Angiotensin II accelerates functional recovery in the rat sciatic nerve in vivo: role of the AT2 receptor and the transcription factor NF-KB. FASEB J. 17, 2094-2096
43. Berk, B. C. (2003) Angiotensin type 2 receptor (AT2R): a challenging twin. Sci. STKE 2003, PE16
44. Steckelings, U. M., Kaschina, E., and Unger, T. (2005) The AT2 receptor: a matter of love and hate. Peptides 26, 1401-1409
45. Gredinger, E., Gerber, A. N, Tamir, Y., Tapscott, S. J., and Bengal, E. (1998) Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells. J. Biol. Chem. 273, 10436-10444
46. Jones, N. C, Fedorov, Y. V., Rosenthal, R. S., and Olwin, B. B. (2001) ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion. J. Cell Physiol. 186, 104-115
47. Jones, N. C, Tyner, K. J., Nibarger, L., Stanley, H. M., Cornelison, D. D., Fedorov, Y. V., and Olwin, B. B. (2005) The p38α/β MAPK functions as a molecular switch to activate the quiescent satellite cell. J. Cell Biol. 169, 105-116
48. Ichiki, T., and Inagami, T. (1995) Expression, genomic organization, and transcription of the mouse angiotensin II type 2 receptor gene. Circ. Res. 76, 693-700
49. Ichiki, T., and Inagami, T. (1995) Transcriptional regulation of the mouse angiotensin II type 2 receptor gene. Hypertension 25, 720-725